Evidence map›Paper›PMID 42237517›Full record

ArticleJournal of breast cancer2026

Breast-Conserving Surgery After Neoadjuvant Chemotherapy Guided by a Supine Magnetic Resonance Imaging Projection Mapping System Visualizing Original Cancer Extent.

Maki Amano, Jun Ozeki, Yumi Koyama, Mayumi Tani, Yuna Kaneko, Chisato Ando, Xiaoyan Tang, Fumi Nozaki, Yasuo Amano, Keiichiro Tada

Abstract read
In one paragraph

Article in Journal of breast cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Maki AmanoDepartment of Radiology, Nihon University Hospital, Tokyo, Japan.ORCID https://orcid.org/0000-0002-4207-5946
Jun OzekiDepartment of Breast and Endocrine Surgery, Nihon University Hospital, Tokyo, Japan.ORCID https://orcid.org/0009-0002-7219-4652
Yumi KoyamaDepartment of Breast and Endocrine Surgery, Nihon University Hospital, Tokyo, Japan.ORCID https://orcid.org/0009-0009-1983-3620
Mayumi TaniDepartment of Breast and Endocrine Surgery, Nihon University Hospital, Tokyo, Japan.ORCID https://orcid.org/0009-0009-3737-0842
Yuna KanekoDivision of Radiological Technology, Nihon University Hospital, Tokyo, Japan.ORCID https://orcid.org/0009-0009-8223-8891
Chisato AndoDivision of Radiological Technology, Nihon University Hospital, Tokyo, Japan.ORCID https://orcid.org/0009-0002-4025-3312
Xiaoyan TangDepartment of Pathology, Nihon University Hospital, Tokyo, Japan.ORCID https://orcid.org/0000-0002-4591-5883
Fumi NozakiDepartment of Pathology, Nihon University Hospital, Tokyo, Japan.ORCID https://orcid.org/0000-0002-4384-3775
Yasuo AmanoDepartment of Radiology, Nihon University Hospital, Tokyo, Japan.ORCID https://orcid.org/0000-0001-5058-4137
Keiichiro TadaDepartment of Breast and Endocrine Surgery, Nihon University Itabashi Hospital, Tokyo, Japan.ORCID https://orcid.org/0000-0002-5395-986X

Funding

Japan Society for the Promotion of Science Kiban C 16K10326
6 · The paper itself

Abstract

It is ideal to remove areas where breast cancer existed before neoadjuvant chemotherapy (NAC) in breast-conserving surgery (BCS) after NAC to ensure a pathological response. However, this becomes challenging, particularly when NAC is effective. It is also important to determine the appropriate resection line to maintain breast cosmesis in the absence of residual cancer cells. We aimed to identify magnetic resonance imaging (MRI) findings that enable the removal of the original cancer extent without additional margins outside the cancer boundary in BCS after NAC using an MRI projection mapping system (PMS). We enrolled 36 women with breast cancer in the study. Contrast-enhanced MRI was performed in the prone and supine positions before NAC. Supine unenhanced MRI with skin markers for registration was performed after NAC, one day before surgery. A maximum intensity projection image visualizing both the tumor extent before NAC and skin markers was projected onto the breast using PMS, and BCS was performed. We compared the clinical, pathological, and MRI findings between patients who required additional margins and those who did not require additional margins during BCS using MRI-PMS. Nineteen of the 36 patients did not require additional margins for BCS after NAC using MRI-PMS. These patients had a higher tumor diameter reduction rate and a lower signal ratio between the tumor bed and normal tissue after NAC than those who required additional margins. This study indicates that MRI-PMS allows BCS without additional margins and may facilitate the conservation of normal breast tissue in patients with a greater diameter reduction rate or a lower signal ratio between the tumor bed and normal tissue after NAC.

Indexed as

Breast NeoplasmsMagnetic Resonance ImagingMastectomy, SegmentalMethodsNeoadjuvant Therapy

Identifiers

PMID42237517
PMCPMC13338613

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.